TRT in the UK: separating clinical fact from TikTok testosterone hype

What did @ritchie_trt actually say?

Ritchie's core argument is simple: testosterone enanthate and cypionate are "different" on paper, but in practice you "can get away with doing the exact same thing" with either. He prefers cypionate personally, partly because he finds enanthate ampules less convenient than cypionate vials, and partly because "subcutaneous injections with enanthate can sting, leave more lumps." His final verdict: go with whichever fits your budget.

There's nothing wildly irresponsible here. He's not claiming one is medically superior, he's not prescribing doses, and he's being upfront that his take is based on personal experience. That said, some of what he says deserves a closer look, because the "they're basically the same" framing, while largely defensible, glosses over details that matter to actual patients.

Does the science back this up?

Mostly, yes. The pharmacological case for near-equivalence between testosterone enanthate and cypionate is solid. Both are long-chain esterified testosterones that are hydrolysed in vivo to free testosterone. The difference in ester half-life is marginal in clinical practice.

Behre et al. (1999, Clinical Endocrinology) established that both esters produce comparable serum testosterone peaks and troughs when injected on similar schedules. A review by Bhasin et al. (2010, Journal of Clinical Endocrinology and Metabolism) confirmed that the two esters are used interchangeably in most clinical protocols with no meaningful difference in androgenic or anabolic effect at equivalent doses. The half-life of enanthate is approximately 4.5 days versus roughly 5 days for cypionate, a difference so small that weekly or twice-weekly injection schedules work for both.

So when Ritchie says you can "get away with doing the exact same thing," he's not wrong from a pharmacokinetic standpoint. The symptomatic experience for most patients on stable TRT should be comparable.

What did they get wrong (or right)?

The subcutaneous stinging claim is the most interesting thing he raises, and it's not fabricated. There is reported clinical experience suggesting enanthate causes more injection site reactions than cypionate when administered subcutaneously, likely due to differences in the oil vehicle and ester solubility. Cypionate is typically formulated in cottonseed oil; enanthate is often in sesame or castor oil, which can be more irritating subcutaneously for some individuals.

However, "quite a lot of people" is doing a lot of work there. The evidence here is mostly anecdotal and forum-based. Alhough Spratt et al. (2021, Journal of the Endocrine Society) documented subcutaneous testosterone as effective and generally well-tolerated, head-to-head subcutaneous comparison data for enanthate versus cypionate specifically is thin. Ritchie is essentially reporting community-level anecdata, which isn't worthless, but it's not a clinical finding either.

On the convenience point about ampules versus vials, he's correct that enanthate in the UK is commonly dispensed in single-use glass ampules while cypionate often comes in multi-dose vials. That's a legitimate practical difference, not a pharmacological one, but it genuinely affects patient experience and adherence.

What should you actually know?

If you're on TRT and switching between enanthate and cypionate, the transition is generally straightforward from a clinical standpoint. Most prescribers treat them as interchangeable at equivalent milligram doses. Your testosterone levels should remain stable if the dose and injection frequency are kept consistent.

That said, do not switch formulations without telling your prescribing clinician. Individual responses to oil vehicles vary. If you're doing subcutaneous injections and experience consistent site reactions, this is worth documenting and reporting, not just tolerating because someone on TikTok said enanthate stings. Oil vehicle sensitivities are real and can affect tolerability even when the active compound is identical.

Budget is a legitimate consideration Ritchie raises honestly. In the UK context, enanthate is often cheaper or more readily available through NHS-adjacent routes, while cypionate dominates private TRT clinic formularies. Neither choice is inherently superior medically. Choose based on cost, formulation availability, and your own injection comfort, in conversation with your prescriber.

• Both esters convert to the same free testosterone in your bloodstream.
• Half-life difference is clinically negligible for most injection schedules.
• Subcutaneous stinging with enanthate is reported but not well-studied in head-to-head trials.
• Vial versus ampule format affects convenience, not pharmacology.
• Always inform your clinician before switching formulations.